124 related articles for article (PubMed ID: 38373107)
1. Detection of effusion tumor cells under different storage and processing conditions.
Libert DM; Zhu Y; Wang A; Allard GM; Cheng-Yi Lowe A
Cancer Cytopathol; 2024 May; 132(5):297-308. PubMed ID: 38373107
[TBL] [Abstract][Full Text] [Related]
2. Promise and limits of the CellSearch platform for evaluating pharmacodynamics in circulating tumor cells.
Wang L; Balasubramanian P; Chen AP; Kummar S; Evrard YA; Kinders RJ
Semin Oncol; 2016 Aug; 43(4):464-75. PubMed ID: 27663478
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of effusion tumor cells (ETCs) from remnant pleural effusion specimens.
Zhu Y; Allard GM; Ericson NG; George TC; Kunder CA; Lowe AC
Cancer Cytopathol; 2021 Nov; 129(11):893-906. PubMed ID: 34171181
[TBL] [Abstract][Full Text] [Related]
4. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer.
Dirix L; Buys A; Oeyen S; Peeters D; Liègeois V; Prové A; Rondas D; Vervoort L; Mariën V; Laere SV; Vermeulen P
Breast Cancer Res Treat; 2022 Jun; 193(2):437-444. PubMed ID: 35397078
[TBL] [Abstract][Full Text] [Related]
6. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.
Liu Z; Fusi A; Klopocki E; Schmittel A; Tinhofer I; Nonnenmacher A; Keilholz U
J Transl Med; 2011 May; 9():70. PubMed ID: 21595914
[TBL] [Abstract][Full Text] [Related]
7. Immunofluorescent and molecular characterization of effusion tumor cells reveal cancer site-of-origin and disease-driving mutations.
Zhu Y; Wang A; Allard GM; Nordberg JJ; Nair RV; Kunder CA; Lowe AC
Cancer Cytopathol; 2022 Oct; 130(10):771-782. PubMed ID: 35731106
[TBL] [Abstract][Full Text] [Related]
8. The combination of size-based separation and selection-free technology provides higher circulating tumour cells detection sensitivity than either method alone in patients with metastatic prostate cancer.
Dong L; Zhang Z; Smith K; Kuczler MD; Reyes D; Amend SR; Cho YK; Xue W; Pienta KJ
BJU Int; 2020 Jul; 126(1):191-201. PubMed ID: 32115854
[TBL] [Abstract][Full Text] [Related]
9. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
[TBL] [Abstract][Full Text] [Related]
10. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
[TBL] [Abstract][Full Text] [Related]
11. Microfluidic Isolation of Circulating Tumor Cells and Cancer Stem-Like Cells from Patients with Pancreatic Ductal Adenocarcinoma.
Varillas JI; Zhang J; Chen K; Barnes II; Liu C; George TJ; Fan ZH
Theranostics; 2019; 9(5):1417-1425. PubMed ID: 30867841
[No Abstract] [Full Text] [Related]
12. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
[TBL] [Abstract][Full Text] [Related]
13. A New Size-based Platform for Circulating Tumor Cell Detection in Colorectal Cancer Patients.
Oh BY; Kim J; Lee WY; Kim HC
Clin Colorectal Cancer; 2017 Sep; 16(3):214-219. PubMed ID: 28209483
[TBL] [Abstract][Full Text] [Related]
14. Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer.
Jacobs TW; Prioleau JE; Stillman IE; Schnitt SJ
J Natl Cancer Inst; 1996 Aug; 88(15):1054-9. PubMed ID: 8683636
[TBL] [Abstract][Full Text] [Related]
15. Split-sample analysis of discarded cells from liquid-based Pap smear sampling devices.
Rinas AC; Mittman BW; Le LV; Hartmann K; Cayless J; Singh HK
Acta Cytol; 2006; 50(1):55-62. PubMed ID: 16514841
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis.
Ramirez AB; Bhat R; Sahay D; De Angelis C; Thangavel H; Hedayatpour S; Dobrolecki LE; Nardone A; Giuliano M; Nagi C; Rimawi M; Osborne CK; Lewis MT; Stilwell JL; Kaldjian EP; Schiff R; Trivedi MV
BMC Cancer; 2019 Mar; 19(1):220. PubMed ID: 30871481
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of Circulating Tumor Cell Neoplastic Subpopulations Outlined by Single-Cell Transcriptomics.
Pauken CM; Kenney SR; Brayer KJ; Guo Y; Brown-Glaberman UA; Marchetti D
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638368
[TBL] [Abstract][Full Text] [Related]
18. Effects of different drying methods on smears of canine blood and effusion fluid.
De Witte FG; Hebrard A; Grimes CN; Owens K; Schaefer DM; Zhu X; Fry MM
PeerJ; 2020; 8():e10092. PubMed ID: 33194381
[TBL] [Abstract][Full Text] [Related]
19. Nucleolin Staining May Aid in the Identification of Circulating Prostate Cancer Cells.
Chalfin HJ; Verdone JE; van der Toom EE; Glavaris S; Gorin MA; Pienta KJ
Clin Genitourin Cancer; 2017 Jun; 15(3):e477-e481. PubMed ID: 28153390
[TBL] [Abstract][Full Text] [Related]
20. Analogous detection of circulating tumor cells using the AccuCyte
van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
